Delivery Order 36F79722D0090-36C26223F0255
Award Date
2/27/23
Potential Completion Date
3/15/23
Potential Value
$10K
Federal Agency
Veterans Integrated Service Network 22
Awardee
Grifols USA LLC
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Los Angeles, CA 90032, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Grifols USA LLC was awarded an $11,580.80 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21. The firm fixed price order, which does not have a set-aside designation, calls for the delivery of PROLASTIN-C to the Los Angeles, California area by July 17, 2023. The delivery order was issued under GSA Schedule master contract FSS-61-IB and will support the VA...
Grifols USA LLC was awarded a $10,182.20 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) prime vendor contract vehicle by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5. This firm fixed price order is for the delivery of PROLASTIN C to the Wildwood, Missouri facility, with performance required by March 6, 2023. No set-aside designation was applied to this order to supply the drug to support...
Grifols USA LLC was awarded a $10,162.60 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) prime vendor contract vehicle by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5. This firm fixed price order is for the delivery of PROLASTIN C to the Wildwood, Missouri facility, with performance required by January 9, 2023. No set-aside designation was applied to this order to supply the drug to support...
This delivery order from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 awards Grifols USA LLC $502,920.80 to supply Prolastin-C Liquid, Human 1000mg/vial under the firm fixed price contract. The order is placed against Grifols' Pharmaceuticals and Drugs Schedule contract with the General Services Administration and requires delivery by September 30, 2023. No set-aside provision was applied to this order. Grifols will provide the...
This is a federal contract award from the U.S. Department of Veterans Affairs (VA) to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The $98,175.36 firm-fixed-price delivery order is for the provision of various pharmaceutical products, including Prolastin, Prolastin-C, and immune globulin, to the VA's Integrated Service Network 19. The contract is a delivery order placed against the Pharmaceuticals and Drugs Federal Supply Schedule...
Grifols USA LLC was awarded a $10,241 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5. The order, which does not have a set aside designation, is for the drug PROLASTIN C and has a completion date of February 3, 2023. Performance will take place in Wildwood, Missouri. The contract has a firm fixed price and was awarded on February 1, 2023 under Master GSA...
This federal contract award is a delivery order issued by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19 to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The order is for various pharmacy supplies and pharmaceuticals, including Prolastin, Prolastin-C, and immune globulin, under the Pharmaceuticals and Drugs General Services Administration (GSA) Schedule contract. The total...
This is a delivery order issued by the Veterans Integrated Service Network 20 (VISN 20) of the U.S. Department of Veterans Affairs (VA) to Grifols Therapeutics LLC, a for-profit manufacturer of pharmaceuticals and biopharmaceuticals. The $278,987.52 firm fixed price award is for the provision of unspecified DRUG products under the Pharmaceuticals and Drugs GSA Schedule contract. The order has a period of performance ending on March 15, 2017 and does not utilize a small business set-aside....
This is a delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The $136,024.56 delivery order was issued under the Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB) and has a firm fixed price. The order is for the VA's Veterans Integrated Service Network 19 to procure pharmaceutical products, with a period of performance through September 30,...
This federal contract award is a delivery order under the Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB) held by Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The $145,892.16 award was made by the Department of Veterans Affairs (VA) to Grifols Therapeutics for the delivery of 10 pharmacy orders. The award does not utilize any small business set-asides. Grifols Therapeutics has previously received other delivery orders and purchase...